vorinostat has been researched along with Malaria, Falciparum in 3 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Malaria, Falciparum: Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dow, GS | 1 |
| Chen, Y | 1 |
| Andrews, KT | 2 |
| Caridha, D | 1 |
| Gerena, L | 1 |
| Gettayacamin, M | 1 |
| Johnson, J | 1 |
| Li, Q | 1 |
| Melendez, V | 1 |
| Obaldia, N | 1 |
| Tran, TN | 1 |
| Kozikowski, AP | 1 |
| Diedrich, D | 1 |
| Stenzel, K | 1 |
| Hesping, E | 1 |
| Antonova-Koch, Y | 1 |
| Gebru, T | 1 |
| Duffy, S | 1 |
| Fisher, G | 1 |
| Schöler, A | 1 |
| Meister, S | 1 |
| Kurz, T | 1 |
| Avery, VM | 1 |
| Winzeler, EA | 1 |
| Held, J | 1 |
| Hansen, FK | 1 |
| Nardella, F | 1 |
| Halby, L | 1 |
| Dobrescu, I | 1 |
| Viluma, J | 1 |
| Bon, C | 1 |
| Claes, A | 1 |
| Cadet-Daniel, V | 1 |
| Tafit, A | 1 |
| Roesch, C | 1 |
| Hammam, E | 1 |
| Erdmann, D | 1 |
| Mairet-Khedim, M | 1 |
| Peronet, R | 1 |
| Mecheri, S | 1 |
| Witkowski, B | 1 |
| Scherf, A | 1 |
| Arimondo, PB | 1 |
3 other studies available for vorinostat and Malaria, Falciparum
| Article | Year |
|---|---|
Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors.
Topics: Animals; Antimalarials; Aotidae; Drug Resistance; Enzyme Inhibitors; Histone Deacetylase Inhibitors; | 2008 |
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
Topics: Acetylation; Antimalarials; Hep G2 Cells; Histone Deacetylase Inhibitors; Histones; Humans; Malaria, | 2018 |
Procainamide-SAHA Fused Inhibitors of hHDAC6 Tackle Multidrug-Resistant Malaria Parasites.
Topics: Antimalarials; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Histone Deacetylase 6; H | 2021 |